Millennium Management’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-629,300
Closed -$24.8M – 6866
2023
Q2
$24.8M Buy
+629,300
New +$22.2M 0.01% 1221
2022
Q4
– Sell
-234,200
Closed -$4.2M – 7316
2022
Q3
$4.2M Buy
+234,200
New +$3.07M ﹤0.01% 3064
2022
Q1
– Sell
-50,000
Closed -$836K – 7801
2021
Q4
$836K Buy
+50,000
New +$820K ﹤0.01% 4572
2017
Q1
– Sell
-243,600
Closed -$1.18M – 3945
2016
Q4
$1.18M Buy
+243,600
New +$7.23M ﹤0.01% 2157
2014
Q2
– Sell
-20,100
Closed -$717K – 4007
2014
Q1
$717K Buy
+20,100
New +$678K ﹤0.01% 2422

Millennium Management's ISEE Position: Q3 2023 in Review

Millennium Management sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 3,959,870 shares — an estimated $156M sold.

Millennium Management first reported a position in ISEE in Q4 2013 and held it in 36 quarters. The position peaked at $156M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Millennium Management reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
  • Millennium Management sold 3,959,870 IVERIC bio shares in Q3 2023, an estimated $156M.
  • Millennium Management first reported a position in IVERIC bio in Q4 2013 and held it in 36 quarters.
  • Millennium Management's IVERIC bio position peaked at $156M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.